At the closing bell, the OMXS30 index was down 0.43 percent to 2,517.96, with stocks totaling around 22.5 billion Swedish kronor traded on the Stockholm Stock Exchange. While commodities saw the best performance among the larger industrial sectors, with a stable development, energy was at the bottom with a 2.1 percent decrease.

In terms of leading stocks included in the OMXS30 index, Sinch saw a 3.4 percent increase while Evolution was up 2.2 percent. On the flip side, SBB B had the worst performance with a 4.2 percent decrease, and Electrolux was down 2.9 percent.

The earnings season continued with a focus on smaller companies. Business information company Karnov Group reported an adjusted EBITA result of 175 million kronor in the first quarter, slightly below the expected 180 million according to Modular Finance’s consensus. The revenue increased by 6.5 percent, leading to a 1.3 percent rise in the company’s stock.

Surgical simulator company Surgical Science showed an increase in revenue and higher adjusted operating income in the first quarter compared to the same period last year. The company also adjusted its goals for 2026, resulting in a 5.4 percent increase in its stock.

Wind power company Eolus Vind demonstrated a significant increase in revenue to 1.975 billion kronor, with a positive operating profit of 164 million kronor in the quarter. However, the stock fell by 11 percent.

The Financial Supervisory Authority, FI, imposed a sanction of 12.5 million kronor on Swedbank for violations of security protection regulations, leading to a 0.2 percent increase in the bank’s stock.

Real estate company Stendörren declined by 4.7 percent after completing a directed new share issue of approximately 300 million kronor before transaction costs. The subscription price was set at 194 kronor per share, representing a discount of about 3.5 percent compared to the latest closing price on Tuesday.

Installation company Bravida was demanded to pay 11.4 million kronor by Region Skåne due to extensive fraud. A thorough investigation by Region Skåne revealed that overbilling was more prevalent than previously known, causing the stock to drop by 1.4 percent.

In insider news, Nyfosa’s CEO Carl-Johan Hugner made his first stock purchase in the company for 15 million kronor, resulting in a 0.2 percent decline in the stock. Additionally, Evolution’s North America chief, Jakob Claesson, purchased shares worth 2.3 million kronor.

On the analysis front, Aktiespararna issued a buy recommendation on Nordnet, leading to a 0.7 percent increase in the stock. Kepler Cheuvreux downgraded Sveafastigheter from buy to hold, causing a 3.5 percent decrease in the stock.

Business magazine Affärsvärlden recommended buying Stillfront, resulting in a 0.1 percent increase in the stock. They also gave a buy stamp to Surgical Science.

Shares: